Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor

Cited by papers we hold 9

• Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence · 2019
  No notice
• Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis · 2018
  No notice
• Clinical and Molecular Spectrum of Liposarcoma · 2018
  No notice
• PPAR and Oxidative Stress: Con() Catenating NRF2 and FOXO · 2012
  No notice
• Liposarcoma: Molecular Genetics and Therapeutics · 2011
  No notice
• The Role of PPARs in Cancer · 2008
  No notice
• Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential · 2007
  No notice
• A phase II trial with rosiglitazone in liposarcoma patients · 2003
  No notice
• Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists · 2000
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.